Skip to main content
. 2010 Mar 10;2:1–11.

Table 1.

Postulated phenotypic changes undergone by breast cancer cells during EMT52,53

Loss of epithelial markers Gain of mesenchymal markers
E-cadherin (CDH1) Vimentin
γ-cadherin Fibronectin
Zonula occludens-1 (ZO1) N-cadherin (CDH2)
Occludin α-smooth muscle actin (α-SMA)
Cytokeratin 8, cytokeratin 18